NCT04375553

Brief Summary

Patients with chronic kidney disease (CKD), especially those who are on dialysis, have a high prevalence of cardiovascular mortality and among the risk factors; inflammation and oxidative stress stand out. Furthermore, recently this scenario, beyond those alterations found in these patients, it has been suggested that the imbalance gut microbiota might be a new factor of cardiovascular risk. Some treatment strategies have been studied in order to modulate the gut microbiota and inflammation, such as the implementation of exercise programs. However, the effects of exercise on the modulation of the gut microflora and inflammation have not been evaluated in these patients. The aim of this project is to investigate possible changes in gut microbiota, levels of uremic toxins and inflammatory and cardiovascular markers in CKD patients on hemodialysis, after application of a training program with aerobic exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

April 25, 2019

Completed
1 year until next milestone

First Posted

Study publicly available on registry

May 5, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

January 5, 2022

Status Verified

January 1, 2022

Enrollment Period

4.9 years

First QC Date

April 25, 2019

Last Update Submit

January 4, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Inflammatory biomarkers

    Get blood samples to evaluate changes in the expression of transcription factors (nuclear factor erythroid 2-related factor 2 and Nuclear Factor-kB) that modulate inflammation.

    12 weeks

  • Uremic toxins

    Evaluation of P-Cresyl Sulfate, Indoxyl Sulfate (IS), Indole 3-Acetic Acid, Trimethyl N-oxide (TMAO) and lipopolysaccharides (LPSs).

    12 weeks

Study Arms (2)

Exercise group

ACTIVE COMPARATOR

Intradialytic aerobic exercise, 3 times a week, for 12 weeks.

Other: Aerobic exercise

Non-exercise group

NO INTERVENTION

Without intradialytic aerobic exercise for 12 weeks.

Interventions

Intradialytic aerobic exercise

Exercise group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Sedentary men and women between the ages of 18 and 60;
  • patients with hemodialysis only with vascular access arteriovenous fistula who have been in dialysis for more than 6 months
  • patients with hemoglobin levels greater than 10 mg / dL.

You may not qualify if:

  • Patients taking catabolizing drugs, vitamin supplements, antioxidants, probiotics, prebiotics, symbiotics and antibiotics;
  • patients with autoimmune, infectious, cancer, AIDS,
  • patients with clinically unstable diseases (AMI less than 1 year, unstable angina, atrial fibrillation, significant cardiac arrhythmia and acute disease in the last month)
  • patients with frequent hypotension during dialysis
  • patients with chronic obstructive pulmonary disease and glycemic lability;
  • incapacitated to perform exercise (amputation without prosthesis);
  • musculoskeletal pain at rest or with minimal physical activity,
  • inability to sit or walk without assistance,
  • dyspnoea at rest or at slight exertion (NYHA III and IV).
  • impediment to completing the proposed exercise protocol (travel, imminent renal transplantation).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Denise Mafra

Rio de Janeiro, Rio de Janeiro, 22260-050, Brazil

Location

Related Publications (2)

  • Brito JS, Borges NA, Reis DCMV, Silva GSD, Fonseca LDS, Ribeiro MMF, Chermut TR, Moura MC, Oliveira LC, Paiva BR, Cardozo LF, Capistrano ESM, Mafra D. Effects of intradialytic bicycle ergometer exercise on transcription factors NF-kB and Nrf2 in patients with chronic kidney disease: A randomized crossover clinical trial. J Bodyw Mov Ther. 2024 Oct;40:1492-1501. doi: 10.1016/j.jbmt.2024.08.003. Epub 2024 Aug 8.

  • Brito JS, Reis D, Silva G, Fonseca L, Ribeiro M, Chermut T, Oliveira L, Borges NA, Ribeiro-Alves M, Mafra D. Bicycle ergometer exercise during hemodialysis and its impact on quality of life, aerobic fitness and dialysis adequacy: A pilot study. Complement Ther Clin Pract. 2022 Nov;49:101669. doi: 10.1016/j.ctcp.2022.101669. Epub 2022 Sep 17.

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Exercise

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Denise Mafra, PhD

    Federal university fluminense

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2019

First Posted

May 5, 2020

Study Start

January 1, 2017

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

January 5, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations